ArticleSouth Asian journal of cancer

Efficacy and safety of nimotuzumab in unresectable, recurrent, and/or metastatic squamous cell carcinoma of the head and neck: A hospital-based retrospective evidence.

Sundaram Subramanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.